EX-10.3 4 reph-ex103_327.htm EX-10.3 Execution VersionMaster Manufacturing Services Agreement • May 5th, 2020 • England
Contract Type FiledMay 5th, 2020 Jurisdiction[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Master Manufacturing Services Agreement 14 JULY 2017Master Manufacturing Services Agreement • August 11th, 2017 • Recro Pharma, Inc. • Pharmaceutical preparations • England
Contract Type FiledAugust 11th, 2017 Company Industry JurisdictionPatheon's liability for Active Materials calculated in accordance with Section 2.2 of the Master Agreement for any Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: